The TandemHeart® pVAD™ in the treatment of acute fulminant myocarditis

Wissam Khalife, Biswajit Kar

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump. Acute myocarditis has a high mortality rate and may necessitate heart transplantation. The best short-term therapy available to support the patient may be a percutaneous left ventricular assist device. One such unit, the TandemHeart® percutaneous ventricular assist device, can enable patients to recover in a few days. Two of our patients who experienced profound, therapyresistant heart failure arising from acute myocarditis were successfully supported by the TandemHeart. To the best of our knowledge, these are the 1st reported cases in which the TandemHeart percutaneous ventricular assist device served as a bridge to recovery from acute fulminant myocarditis.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalTexas Heart Institute Journal
Volume34
Issue number2
StatePublished - 2007
Externally publishedYes

Fingerprint

Myocarditis
Heart-Assist Devices
Heart Transplantation
Therapeutics
Shock
Heart Failure
Hemodynamics
Steroids
Mortality

Keywords

  • Assisted circulation/methods
  • Heart-assist devices
  • Myocarditis/ complications/surgery/therapy
  • Shock, cardiogenic/therapy
  • Treatment outcome
  • Ventricular dysfunction, left/etiology/therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The TandemHeart® pVAD™ in the treatment of acute fulminant myocarditis. / Khalife, Wissam; Kar, Biswajit.

In: Texas Heart Institute Journal, Vol. 34, No. 2, 2007, p. 209-213.

Research output: Contribution to journalArticle

@article{c49c9f4246fa4192b005efcace410ce0,
title = "The TandemHeart{\circledR} pVAD™ in the treatment of acute fulminant myocarditis",
abstract = "Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump. Acute myocarditis has a high mortality rate and may necessitate heart transplantation. The best short-term therapy available to support the patient may be a percutaneous left ventricular assist device. One such unit, the TandemHeart{\circledR} percutaneous ventricular assist device, can enable patients to recover in a few days. Two of our patients who experienced profound, therapyresistant heart failure arising from acute myocarditis were successfully supported by the TandemHeart. To the best of our knowledge, these are the 1st reported cases in which the TandemHeart percutaneous ventricular assist device served as a bridge to recovery from acute fulminant myocarditis.",
keywords = "Assisted circulation/methods, Heart-assist devices, Myocarditis/ complications/surgery/therapy, Shock, cardiogenic/therapy, Treatment outcome, Ventricular dysfunction, left/etiology/therapy",
author = "Wissam Khalife and Biswajit Kar",
year = "2007",
language = "English (US)",
volume = "34",
pages = "209--213",
journal = "Texas Heart Institute Journal",
issn = "0730-2347",
publisher = "Texas Heart Institute",
number = "2",

}

TY - JOUR

T1 - The TandemHeart® pVAD™ in the treatment of acute fulminant myocarditis

AU - Khalife, Wissam

AU - Kar, Biswajit

PY - 2007

Y1 - 2007

N2 - Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump. Acute myocarditis has a high mortality rate and may necessitate heart transplantation. The best short-term therapy available to support the patient may be a percutaneous left ventricular assist device. One such unit, the TandemHeart® percutaneous ventricular assist device, can enable patients to recover in a few days. Two of our patients who experienced profound, therapyresistant heart failure arising from acute myocarditis were successfully supported by the TandemHeart. To the best of our knowledge, these are the 1st reported cases in which the TandemHeart percutaneous ventricular assist device served as a bridge to recovery from acute fulminant myocarditis.

AB - Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump. Acute myocarditis has a high mortality rate and may necessitate heart transplantation. The best short-term therapy available to support the patient may be a percutaneous left ventricular assist device. One such unit, the TandemHeart® percutaneous ventricular assist device, can enable patients to recover in a few days. Two of our patients who experienced profound, therapyresistant heart failure arising from acute myocarditis were successfully supported by the TandemHeart. To the best of our knowledge, these are the 1st reported cases in which the TandemHeart percutaneous ventricular assist device served as a bridge to recovery from acute fulminant myocarditis.

KW - Assisted circulation/methods

KW - Heart-assist devices

KW - Myocarditis/ complications/surgery/therapy

KW - Shock, cardiogenic/therapy

KW - Treatment outcome

KW - Ventricular dysfunction, left/etiology/therapy

UR - http://www.scopus.com/inward/record.url?scp=34447550454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447550454&partnerID=8YFLogxK

M3 - Article

C2 - 17622371

AN - SCOPUS:34447550454

VL - 34

SP - 209

EP - 213

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

SN - 0730-2347

IS - 2

ER -